chr2-42048839-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_138370.3(PKDCC):c.639+1G>T variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000617 in 1,457,592 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_138370.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKDCC | ENST00000294964.6 | c.639+1G>T | splice_donor_variant, intron_variant | Intron 1 of 6 | 1 | NM_138370.3 | ENSP00000294964.5 | |||
PKDCC | ENST00000401498.6 | n.497+1G>T | splice_donor_variant, intron_variant | Intron 2 of 7 | 5 | ENSP00000385220.2 | ||||
PKDCC | ENST00000485578.1 | n.260+1G>T | splice_donor_variant, intron_variant | Intron 1 of 1 | 2 | |||||
PKDCC | ENST00000492861.1 | n.65+1G>T | splice_donor_variant, intron_variant | Intron 1 of 2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000378 AC: 6AN: 158918Hom.: 0 AF XY: 0.0000345 AC XY: 3AN XY: 86940
GnomAD4 exome AF: 0.00000613 AC: 8AN: 1305406Hom.: 0 Cov.: 33 AF XY: 0.00000781 AC XY: 5AN XY: 640114
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152186Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74350
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.639+1G>T intronic variant results from a G to T substitution one nucleotide after coding exon 1 of the PKDCC gene. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on data from gnomAD, the T allele has an overall frequency of 0.004% (6/158918) total alleles studied. The highest observed frequency was 0.027% (6/22264) of Latino alleles. This variant has been identified in trans with another PKDCC variant in an individual with short stature, macrocephaly, rhizomelia, and brachydactyly (Pagnamenta, 2023). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Based on the available evidence, this alteration is classified as likely pathogenic. -
not provided Pathogenic:1
This sequence change affects a donor splice site in intron 1 of the PKDCC gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PKDCC are known to be pathogenic (PMID: 19097194, 30478137). This variant is present in population databases (rs763243200, gnomAD 0.03%). Disruption of this splice site has been observed in individuals with clinical features of PKDCC-related skeletal dysplasia (PMID: 30478137; Invitae). ClinVar contains an entry for this variant (Variation ID: 522098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Rhizomelic limb shortening with dysmorphic features Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at